![State of the Union COVID-19](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/us/us_22920_masthead-webinar_state-of-the-union-covid-19-1920x1080.png?h=1080&iar=0&w=1920&revision=3634c6c6-ef96-47a1-9fa7-0286804f9c8b,5249850100177387904&hash=F6B3D1171A58C2C068E60E36FC112764)
Preparing for the inevitable: Government enforcement and qui tams looming for healthcare and life sciences companies
Event Details
Webinar
United States | May 27, 2020Please join us for a webinar focused on preparing healthcare and life sciences companies for the looming government enforcement and qui tam activity likely to result from the COVID-19 pandemic, including:
- Regulatory traps for the unwary: Understanding the current pandemic-related regulatory issues which will be the basis for future government enforcement and qui tam activity.
- Know the players: Which government institutions and personnel will be involved in enforcement activities and what their priorities relevant to healthcare and life sciences companies will be.
- Preparing the defense: What companies should be doing now to minimize risk and position for best possible outcomes.
Speakers
- Samuel Ramer, Partner, Norton Rose Fulbright US LLP
- Keith Rosen, Head of Risk Advisory, United States, Norton Rose Fulbright US LLP
- Chandra Westergaard, Partner, Norton Rose Fulbright US LLP
- Jeff Wurzburg, Senior Counsel, Norton Rose Fulbright US LLP